# MCP Tool-Call Transcript

**Criteria:** AC-10 (adapter integration + tool-call log)  
**Generated:** 2026-09-12T23:18:42+00:00  
**Regenerate:** `python scripts/generate_evidence.py`

> All data is synthetic. Identifiers are pseudonymised in traces (NFR-05).

---

Every call below went through `langchain-mcp-adapters` to the MCP server subprocess over stdio.

## `patient_lookup`

_Verify the record and confirm documented allergies before reconciling._

**Arguments**
```json
{
  "mrn": "MRN-3001"
}
```

**Result** (228.2 ms)
```json
{
  "found": true,
  "mrn": "MRN-3001",
  "name": "Marcus Adeyemi",
  "age": 68,
  "sex": "M",
  "admission_date": "2026-09-01",
  "attending": "Dr. P. Nakamura",
  "ward": "General Medicine 3B",
  "primary_diagnosis": "Deep vein thrombosis with pulmonary embolism",
  "problem_list": [
    "Deep vein thrombosis with pulmonary embolism",
    "Atrial fibrillation",
    "Chronic obstructive pulmonary disease",
    "Oropharyngeal candidiasis"
  ],
  "pre_admission_medications": [
    "Warfarin 5 mg once daily",
    "Tiotropium 18 mcg once daily",
    "Atorvastatin 40 mg once daily",
    "Omeprazole 20 mg once daily"
  ],
  "allergies": [
    "Sulfa drugs"
  ],
  "prior_admissions_12mo": 1,
  "insurance_tier": "standard",
  "preferred_clinic": "Riverside Anticoagulation Clinic"
}
```

---

## `medication_interaction_check`

_CASE-003 discharge list — expected to surface a contraindicated pair._

**Arguments**
```json
{
  "medications": [
    "Warfarin 7.5 mg",
    "Amiodarone 200 mg",
    "Fluconazole 100 mg",
    "Atorvastatin 40 mg",
    "Tiotropium 18 mcg"
  ]
}
```

**Result** (270.4 ms)
```json
{
  "medications_checked": [
    "warfarin",
    "amiodarone",
    "fluconazole",
    "atorvastatin",
    "tiotropium"
  ],
  "pairs_evaluated": 10,
  "interactions_found": 3,
  "interactions": [
    {
      "drug_a": "warfarin",
      "drug_b": "fluconazole",
      "checked_pair": "fluconazole|warfarin",
      "severity": "contraindicated",
      "description": "Fluconazole strongly inhibits CYP2C9, the main enzyme clearing S-warfarin. INR can rise sharply within 2-3 days, with a substantial bleeding risk.",
      "recommendation": "Avoid the combination where an alternative antifungal exists. If unavoidable, reduce the warfarin dose and recheck INR within 3 days with anticoagulation clinic oversight."
    },
    {
      "drug_a": "warfarin",
      "drug_b": "amiodarone",
      "checked_pair": "amiodarone|warfarin",
      "severity": "major",
      "description": "Amiodarone inhibits warfarin metabolism and its long half-life means the effect accumulates over weeks. INR typically rises with a delayed onset.",
      "recommendation": "Anticipate a warfarin dose reduction of roughly one third. Recheck INR within 3-5 days and monitor weekly for the first month."
    },
    {
      "drug_a": "amiodarone",
      "drug_b": "atorvastatin",
      "checked_pair": "amiodarone|atorvastatin",
      "severity": "moderate",
      "description": "Amiodarone inhibits CYP3A4, raising atorvastatin exposure and the risk of myopathy.",
      "recommendation": "Limit atorvastatin to 20 mg daily with amiodarone; counsel on muscle pain."
    }
  ],
  "high_alert_medications": [
    "amiodarone",
    "warfarin"
  ],
  "highest_severity": "contraindicated",
  "pharmacist_review_required": true,
  "advisory": "PHARMACIST REVIEW REQUIRED before dispensing: warfarin + fluconazole (contraindicated
```

---

## `medication_interaction_check`

_CASE-002 pre-admission list — NSAID in heart failure._

**Arguments**
```json
{
  "medications": [
    "Furosemide 20 mg",
    "Metoprolol succinate 25 mg",
    "Apixaban 5 mg",
    "Metformin 1000 mg",
    "Ibuprofen 400 mg"
  ]
}
```

**Result** (301.9 ms)
```json
{
  "medications_checked": [
    "furosemide",
    "metoprolol succinate",
    "apixaban",
    "metformin",
    "ibuprofen"
  ],
  "pairs_evaluated": 10,
  "interactions_found": 3,
  "interactions": [
    {
      "drug_a": "furosemide",
      "drug_b": "ibuprofen",
      "checked_pair": "furosemide|ibuprofen",
      "severity": "major",
      "description": "NSAIDs blunt the diuretic and natriuretic effect of loop diuretics and reduce renal perfusion, precipitating heart-failure decompensation and acute kidney injury.",
      "recommendation": "Stop the NSAID. Use acetaminophen for analgesia in heart failure and chronic kidney disease."
    },
    {
      "drug_a": "apixaban",
      "drug_b": "ibuprofen",
      "checked_pair": "apixaban|ibuprofen",
      "severity": "major",
      "description": "Additive bleeding risk: NSAIDs impair platelet function and cause gastric mucosal injury alongside direct oral anticoagulation.",
      "recommendation": "Avoid. If an NSAID is unavoidable, add gastroprotection and counsel on bleeding signs."
    },
    {
      "drug_a": "furosemide",
      "drug_b": "metformin",
      "checked_pair": "furosemide|metformin",
      "severity": "moderate",
      "description": "Loop diuretics can reduce renal clearance of metformin and raise its plasma concentration.",
      "recommendation": "Check renal function after any diuretic dose increase."
    }
  ],
  "high_alert_medications": [
    "apixaban",
    "furosemide",
    "metformin"
  ],
  "highest_severity": "major",
  "pharmacist_review_required": true,
  "advisory": "PHARMACIST REVIEW REQUIRED before dispensing: furosemide + ibuprofen (major); apixaban + ibuprofen (major)"
}
```

---

## `schedule_followup`

_Compressed window driven by the interaction finding._

**Arguments**
```json
{
  "mrn": "MRN-3001",
  "specialty": "Anticoagulation Clinic",
  "within_days": 3,
  "reason": "INR check after starting two interacting medications",
  "discharge_date": "2026-09-06"
}
```

**Result** (248.3 ms)
```json
{
  "confirmed": true,
  "confirmation_id": "FU-3001-ANT-0909",
  "mrn": "MRN-3001",
  "specialty": "Anticoagulation Clinic",
  "scheduled_date": "2026-09-09",
  "days_from_discharge": 3,
  "requested_within_days": 3,
  "within_requested_window": true,
  "reason": "INR check after starting two interacting medications",
  "modality": "in_person",
  "note": "Booked 3 days after discharge, within the requested 3-day window."
}
```

---

## `schedule_followup`

_No slot fits — the tool must say so rather than book outside the window._

**Arguments**
```json
{
  "mrn": "MRN-1001",
  "specialty": "Pulmonology",
  "within_days": 1,
  "reason": "urgent review",
  "discharge_date": "2026-09-06"
}
```

**Result** (224.7 ms)
```json
{
  "confirmed": true,
  "confirmation_id": "FU-1001-PUL-0910",
  "mrn": "MRN-1001",
  "specialty": "Pulmonology",
  "scheduled_date": "2026-09-10",
  "days_from_discharge": 4,
  "requested_within_days": 1,
  "within_requested_window": false,
  "reason": "urgent review",
  "modality": "in_person",
  "note": "NO SLOT within 1 days. Booked the earliest available at 4 days. If the clinical window is firm, escalate to the scheduling desk for an overbook or arrange an interim telephone review."
}
```

---

## `check_transport_availability`

_CASE-002 patient has limited mobility and no caregiver._

**Arguments**
```json
{
  "mrn": "MRN-2001",
  "transport_type": "wheelchair_van",
  "discharge_date": "2026-09-08"
}
```

**Result** (269.7 ms)
```json
{
  "available": true,
  "mrn": "MRN-2001",
  "transport_type": "wheelchair_van",
  "date": "2026-09-08",
  "slots_remaining": 3,
  "daily_capacity": 12,
  "lead_time_hours": 12,
  "cost_band": "medium",
  "note": "3 slot(s) remaining. Book at least 12h ahead."
}
```

---

## Resource `discharge://protocol/heart-failure`

```json
{
  "found": true,
  "title": "Discharge protocol \u2014 Acute decompensated heart failure",
  "aliases": [
    "chf",
    "hf",
    "congestive heart failure",
    "acute decompensated heart failure"
  ],
  "required_before_discharge": [
    "Patient at or near documented dry weight for at least 24 hours",
    "Oral diuretic regimen established for a minimum of 24 hours before discharge",
    "Basic metabolic panel within 24 hours of discharge, with potassium and creatinine stable",
    "Guideline-directed medical therapy reviewed and uptitrated where blood pressure and renal function allow",
    "Patient or caregiver able to demonstrate daily weight monitoring"
  ],
  "follow_up": {
    "primary": "Cardiology or heart-failure clinic within 7 days of discharge",
    "high_risk": "Within 3-5 days, plus a telephone check at 48-72 hours",
    "labs": "Basic metabolic panel within 5-7 days of any diuretic or RAAS-agent change"
  },
  "education_priorities": [
    "Weigh at the same time each morning and record it",
    "Report a gain of more than 2 kg (about 4 lb) in 2 days or 2.5 kg in a week",
    "Limit sodium to under 2 grams per day",
    "Never stop a heart medication without sp
```

---

## Resource `discharge://protocol/dvt-pe`

```json
{
  "found": true,
  "title": "Discharge protocol \u2014 Venous thromboembolism (DVT / PE)",
  "aliases": [
    "dvt",
    "pe",
    "pulmonary embolism",
    "deep vein thrombosis",
    "venous thromboembolism"
  ],
  "required_before_discharge": [
    "Anticoagulation regimen defined with an explicit intended duration",
    "For warfarin: INR trending into range and a documented anticoagulation-clinic appointment",
    "Bleeding-risk counselling completed and documented",
    "Interacting medications reviewed against the anticoagulant"
  ],
  "follow_up": {
    "primary": "Anticoagulation clinic within 3-7 days",
    "high_risk": "INR within 3 days where an interacting medication has been started",
    "labs": "INR per anticoagulation-clinic schedule; full blood count at 2 weeks"
  },
  "education_priorities": [
    "Take the anticoagulant at the same time every day and never double a missed dose",
    "Recognise bleeding that needs urgent attention",
    "Tell every clinician and dentist about the anticoagulant",
    "Keep vitamin K intake steady if taking warfarin"
  ],
  "red_flags": [
    "Bleeding that will not stop, or blood in the urine or stool",
    "A severe headache or
```

---

## Resource `formulary://medications`

```json
{
  "generated": "2026-09-12T23:18:45",
  "note": "SYNTHETIC formulary generated for this capstone. Not a clinical reference.",
  "medication_count": 14,
  "medications": [
    "amiodarone",
    "amoxicillin-clavulanate",
    "apixaban",
    "atorvastatin",
    "fluconazole",
    "furosemide",
    "ibuprofen",
    "lisinopril",
    "metformin",
    "metoprolol succinate",
    "omeprazole",
    "sacubitril-valsartan",
    "spironolactone",
    "warfarin"
  ],
  "high_alert_medications": [
    "amiodarone",
    "apixaban",
    "furosemide",
    "insulin",
    "metformin",
    "sacubitril-valsartan",
    "spironolactone",
    "warfarin"
  ],
  "interaction_pairs_known": 15,
  "severity_scale": [
    "minor",
    "moderate",
    "major",
    "contraindicated"
  ],
  "escalation_rule": "Any interaction of major or contraindicated severity requires pharmacist review before discharge medications are dispensed."
}
```

---

